New Zealand at a glance
- Population
- 5.3 million 2025
- Life expectancy at birth
- 82.0 years, 2024
- People aged 65 and over
- 17.6 % of people, 2025
- Health spending per person
- 5,022 US$ per person, 2024
- Doctors
- 3.61 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
New Zealand Nutrigenomics Market Industry Trends and Forecast to 2034: Segmented by (Product, Channel, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$19.4 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $6.8 Mn | — | — |
| 2025 (base) | $7.8 Mn | +$1.0 Mn | — |
| 2026 (forecast) | $8.9 Mn | +$1.2 Mn | +14.9% |
| 2027 (forecast) | $10.3 Mn | +$1.3 Mn | +32% |
| 2028 (forecast) | $11.8 Mn | +$1.5 Mn | +51.7% |
| 2029 (forecast) | $13.6 Mn | +$1.8 Mn | +74.3% |
| 2030 (forecast) | $15.6 Mn | +$2.0 Mn | +100.3% |
| 2031 (forecast) | $17.9 Mn | +$2.3 Mn | +130.1% |
| 2032 (forecast) | $20.6 Mn | +$2.7 Mn | +164.4% |
| 2033 (forecast) | $23.7 Mn | +$3.1 Mn | +203.8% |
| 2034 (forecast) | $27.2 Mn | +$3.5 Mn | +249% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $7.8 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $27.2 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 14.9% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, channel and distribution channel (see all) |
| Key players | Nutrigenomix, GenoPalate, DNAfit, Viome, ZOE (see all) |
| Regulator in New Zealand | Medsafe and MPISource: Medsafe. Checked 14 Nov 2026.Source: Ministry for Primary Industries. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Nutrigenomics uses genetic tests to give personal diet and nutrition advice based on how genes affect the body's use of food.
Key segments of the nutrigenomics market include product (DNA Diet Tests, Personalized Supplements and Coaching Services) and channel (Online, Clinics and Fitness Centers).
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the nutrigenomics market.
Routine use of genomics in screening, pharmacy and primary care gives the nutrigenomics market large room to grow.
Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the nutrigenomics market.
The nutrigenomics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medsafe, part of the Ministry of Health, approves medicines before they can be sold.[1] Dietary supplements are regulated as food, under the Ministry for Primary Industries (MPI).[2]
[1] Medsafe. Checked 14 Nov 2026.
[2] Ministry for Primary Industries. Checked 14 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern nutrigenomics products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in New Zealand.
What doctors and scientists are doing in Nutrigenomics right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.
From our blog
New Zealand · 1 shared keyword
New Zealand · 1 shared keyword
New Zealand · 1 shared keyword
New Zealand · 1 shared keyword
New Zealand · 1 shared keyword
New Zealand
Pharmaceuticals · New Zealand
Digital Health · New Zealand
Healthcare Services · New Zealand
Healthcare Services · New Zealand
Medical Devices · New Zealand
Digital Health · New Zealand